Usefulness of outpatient bleeding risk index to predict bleeding complications in patients with long-term oral anticoagulation undergoing coronary stenting

American Journal of Cardiology

Volumn 106, Issue 2, 2010, Pages 175-179

  Airaksinen, K E Juhani ^a   Suurmunne, Hanna ^a   Porela, Pekka ^a   Niemel, Matti ^b   Vikman, Saila ^c   Puurunen, Marja ^d   Annala, Antti Pekka ^e   Biancari, Fausto ^b   Karjalainen, Pasi P ^e  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; HEPARIN; HIRULOG; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ASSESSMENT TOOL; CORONARY STENT; FEMALE; FIBRINOLYTIC THERAPY; FINLAND; FOLLOW UP; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HOME CARE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT BLEEDING RISK INDEX; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORTALITY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS;

EID: 77955717864     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.03.011     Document Type: Article

References (18)

1. P. Karjalainen, S. Vikman, M. Niemel, P. Porela, A. Ylitalo, M. Vaittinen, M. Puurunen, T. Airaksinen, K. Nyman, T. Vahlberg, and K. Airaksinen Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J 29 2008 1001 1010
2. P. Korkeila, A. Ylitalo, J. Koistinen, and K. Airaksinen Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: a prospective serial venographic study Ann Med 41 2009 216 223
3. A. Annala, P. Karjalainen, P. Porela, K. Nyman, A. Ylitalo, and K. Airaksinen Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment Am J Cardiol 102 2008 386 390
4. P. Karjalainen, P. Porela, A. Ylitalo, S. Vikman, K. Nyman, M. Vaittinen, T. Airaksinen, M. Niemel, T. Vahlberg, and K. Airaksinen Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting Eur Heart J 28 2007 726 732
5. S. Rietbrock, E. Heeley, J. Plumb, and T. van Staa Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme Am Heart J 156 2008 57 64
6. R. Beyth, L. Quinn, and C. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99
7. S. Rao, K. O'Grady, K. Pieper, C. Granger, L. Newby, K. Mahaffey, D. Moliterno, A. Lincoff, P. Armstrong, F. Van de Werf, R. Califf, and R. Harrington A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816
8. J. Eikelboom, S. Mehta, S. Anand, C. Xie, K. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
9. A. Rubboli, J. Halperin, K. Airaksinen, M. Buerke, E. Eeckhout, S. Freedman, A. Gershlick, A. Schlitt, H. Tse, F. Verheugt, and G. Lip Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting An expert consensus document with focus on atrial fibrillation Ann Med 40 2008 428 436
10. M. Nguyen, Y. Lim, A. Walton, J. Lefkovits, G. Agnelli, S. Goodman, A. Budaj, D. Gulba, J. Allegrone, and D. Brieger Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28 2007 1717 1722
11. H. Lahtela, P. Karjalainen, M. Niemel, S. Vikman, K. Kervinen, A. Ylitalo, M. Puurunen, P. Porela, K. Nyman, S. Hinkka-Yli-Salomki, and K. Airaksinen Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? Thromb Haemost 102 2009 1227 1233
12. E. Hylek, C. Evans-Molina, C. Shea, L. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
13. M. Enajat, S. Teerenstra, J. van Kuilenburg, A. van Sorge-Greve, M. Albers-Akkers, F. Verheugt, and G. Pop Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study Drugs Aging 26 2009 585 593
14. S. Gulmez, A. Lassen, C. Aalykke, M. Dall, A. Andries, B. Andersen, J. Hansen, M. Andersen, and J. Hallas Do statins protect against upper gastrointestinal bleeding? Br J Clin Pharmacol 67 2009 460 465
15. V. Fuster, L. Rydn, D. Cannom, H. Crijns, A. Curtis, K. Ellenbogen, J. Halperin, J. Le Heuzey, G. Kay, J. Lowe, S. Olsson, E. Prystowsky, J. Tamargo, and S. Wann ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Eur Heart J 27 2006 1979 2030
16. S. Mattichak, P. Reed, M. Gallagher, J. Boura, W. O'Neill, and J. Kahn Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction J Interv Cardiol 18 2005 163 166
17. R. Sørensen, M. Hansen, S. Abildstrom, A. Hvelplund, C. Andersson, C. Jørgensen, J. Madsen, P. Hansen, L. Køber, C. Torp-Pedersen, and G. Gislason Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
18. P. Ho, T. Maddox, L. Wang, S. Fihn, R. Jesse, E. Peterson, and J. Rumsfeld Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 2009 937 944